|
1
|
Rizzolo LJ, Peng S, Luo Y and Xiao W:
Integration of tight junctions and claudins with the barrier
functions of the retinal pigment epithelium. Prog Retin Eye Res.
30:296–323. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Sparrow JR, Hicks D and Hamel CP: The
retinal pigment epithelium in health and disease. Curr Mol Med.
10:802–823. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
He S, Chen Y, Khankan R, et al: Connective
tissue growth factor as a mediator of intraocular fibrosis. Invest
Ophthalmol Vis Sci. 49:4078–4088. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kaczmarek R and Misiuk-Hojlo M:
Patomechanisms in proliferative vitreoretinopathy. Klin Oczna.
113:64–67. 2011.PubMed/NCBI
|
|
5
|
Lei H, Rhéaume MA and Kazlauskas A: Recent
developments in our understanding of how platelet-derived growth
factor (PDGF) and its receptors contribute to proliferative
vitreoretinopathy. Exp Eye Res. 90:376–381. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lei H, Rhéaume MA, Velez G, Mukai S and
Kazlauskas A: Expression of PDGFRalpha is a determinant of the PVR
potential of ARPE19 cells. Invest Ophthalmol Vis Sci. 52:5016–5021.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Umazume K, Barak Y, McDonald K, Liu L,
Kaplan HJ and Tamiya S: Proliferative vitreoretinopathy in the
Swine-a new model. Invest Ophthalmol Vis Sci. 53:4910–4916. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Asaria RH and Charteris DG: Proliferative
vitreoretinopathy: developments in pathogenesis and treatment.
Compr Ophthalmol Update. 7:179–185. 2006.PubMed/NCBI
|
|
9
|
Leiderman YI and Miller JW: Proliferative
vitreoretinopathy: pathobiology and therapeutic targets. Semin
Ophthalmol. 24:62–69. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Sebag J: Shaken not stirred.
Ophthalmology. 108:1177–1178. 2001. View Article : Google Scholar
|
|
11
|
Kim IK and Arroyo JG: Mechanisms in
proliferative vitreoretinopathy. Ophthalmol Clin North Am.
15:81–86. 2002. View Article : Google Scholar
|
|
12
|
Wickham L and Charteris DG: Glial cell
changes of the human retina in proliferative vitreoretinopathy. Dev
Ophthalmol. 44:37–45. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bastiaans J, van Meurs JC, van
Holten-Neelen C, et al: Factor Xa and thrombin stimulate
proinflammatory and profibrotic mediator production by retinal
pigment epithelial cells: a role in vitreoretinal disorders?
Graefes Arch Clin Exp Ophthalmol. 251:1723–1733. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Feist RM Jr, King JL, Morris R,
Witherspoon CD and Guidry C: Myofibroblast and extracellular matrix
origins in proliferative vitreoretinopathy. Graefes Arch Clin Exp
Ophthalmol. 252:347–357. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Halper J and Kjaer M: Basic components of
connective tissues and extracellular matrix: elastin, fibrillin,
fibulins, fibrinogen, fibronectin, laminin, tenascins and
thrombospondins. Adv Exp Med Biol. 802:31–47. 2014. View Article : Google Scholar
|
|
16
|
Zhu W, Wu Y, Cui C, Zhao HM, Ba J, Chen H
and Yu J: Expression of IGFBP6 in proliferative vitreoretinopathy
rat models and its effects on retinal pigment epithelial-J cells.
Mol Med Rep. 9:33–38. 2014.
|
|
17
|
Azzolini C, Pagani IS, Pirrone C, et al:
Expression of VEGF-A, Otx homeobox and p53 family genes in
proliferative vitreoretinopathy. Mediators Inflamm.
2013:8573802013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hou Q, Tang J, Wang Z, et al: Inhibitory
effect of microRNA-34a on retinal pigment epithelial cell
proliferation and migration. Invest Ophthalmol Vis Sci.
54:6481–6488. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Qiu S, Jiang Z, Huang Z, Chen X, Qian X,
Gao Q and Zheng H: Migration of retinal pigment epithelium cells is
regulated by protein kinase Calpha in vitro. Invest Ophthalmol Vis
Sci. 54:7082–7090. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Ahmadieh H, Feghhi M, Tabatabaei H,
Shoeibi N, Ramezani A and Mohebbi MR: Triamcinolone acetonide in
silicone-filled eyes as adjunctive treatment for proliferative
vitreoretinopathy: a randomized clinical trial. Ophthalmology.
115:1938–1943. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Cheema RA, Peyman GA, Fang T, Jones A,
Lukaris AD and Lim K: Triamcinolone acetonide as an adjuvant in the
surgical treatment of retinal detachment with proliferative
vitreoretinopathy. Ophthalmic Surg Lasers Imaging. 38:365–370.
2007.PubMed/NCBI
|
|
22
|
Yasukawa T, Kimura H, Dong J, Tabata Y,
Miyamoto H, Honda Y and Ogura Y: Effect of tranilast on
proliferation, collagen gel contraction, and transforming growth
factor beta secretion of retinal pigment epithelial cells and
fibroblasts. Ophthalmic Res. 34:206–212. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Krott R, Lebek J, Grisanti S, Esser P and
Heimann K: Antiproliferative Wirkung von Genistein auf kultivierte
retinale Pigmentepithelzellen vom Schwein. Ophthalmologica.
214:296–300. 2000.(In German).
|
|
24
|
Koutsandrea CN, Miceli MV, Peyman GA,
Farahat HG and Niesman MR: Ciprofloxacin and dexamethasone inhibit
the proliferation of human retinal pigment epithelial cells in
culture. Curr Eye Res. 10:249–258. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wu WC, Hu DN, Mehta S and Chang YC:
Effects of retinoic acid on retinal pigment epithelium from excised
membranes from proliferative vitreoretinopathy. J Ocul Pharmacol
Ther. 21:44–54. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Sakamoto T, Hinton DR, Kimura H, Spee C,
Gopalakrishna R and Ryan SJ: Vitamin E succinate inhibits
proliferation and migration of retinal pigment epithelial cells in
vitro: therapeutic implication for proliferative vitreoretinopathy.
Graefes Arch Clin Exp Ophthalmol. 234:186–192. 1996. View Article : Google Scholar
|
|
27
|
Handa JT, Murad S and Jaffe GJ: Inhibition
of cultured human RPE cell proliferation and lysyl hydroxylase
activity by hydroxy derivatives of minoxidil. Invest Ophthalmol Vis
Sci. 35:463–469. 1994.PubMed/NCBI
|
|
28
|
Gao Q and Ge J: The inhibition of
Ca2+influx induced by hypericin in cultured human
retinal pigment epithelial cells analyzed by confocal imaging.
Ophthalmic Res. 37:128–135. 2005.
|
|
29
|
Yoo JS, Sakamoto T, Spee C, et al:
cis-Hydroxyproline inhibits proliferation, collagen synthesis,
attachment, and migration of cultured bovine retinal pigment
epithelial cells. Invest Ophthalmol Vis Sci. 38:520–528. 1997.
|
|
30
|
Schmidt JF and Loeffler KU: Toxicity and
antiproliferative effect of aclacinomycin A on RPE cells in vitro.
Curr Eye Res. 15:1112–1116. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wang YS, Hui YN and Wiedemann P: Role of
apoptosis in the cytotoxic effect mediated by daunorubicin in
cultured human retinal pigment epithelial cells. J Ocul Pharmacol
Ther. 18:377–387. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Steinhorst UH, Chen EP, Machemer R and
Hatchell DL: N,N-dimethyladriamycin for treatment of experimental
proliferative vitreoretinopathy: efficacy and toxicity on the
rabbit retina. Exp Eye Res. 56:489–495. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hollborn M, Chen R, Wiedemann P,
Reichenbach A, Bringmann A and Kohen L: Cytotoxic effects of
curcumin in human retinal pigment epithelial cells. PLoS One.
8:e596032013. View Article : Google Scholar
|
|
34
|
Woo JM, Shin DY, Lee SJ, et al: Curcumin
protects retinal pigment epithelial cells against oxidative stress
via induction of heme oxygenase-1 expression and reduction of
reactive oxygen. Mol Vis. 18:901–908. 2012.PubMed/NCBI
|
|
35
|
Rong S, Zhao Y, Bao W, et al: Curcumin
prevents chronic alcohol-induced liver disease involving decreasing
ROS generation and enhancing antioxidative capacity. Phytomedicine.
19:545–550. 2012. View Article : Google Scholar
|
|
36
|
Katsori AM, Chatzopoulou M, Dimas K,
Kontogiorgis C, Patsilinakos A, Trangas T and Hadjipavlou-Litina D:
Curcumin analogues as possible anti-proliferative and
anti-inflammatory agents. Eur J Med Chem. 46:2722–2735. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mohan R, Sivak J, Ashton P, et al:
Curcuminoids inhibit the angiogenic response stimulated by
fibroblast growth factor-2, including expression of matrix
metalloproteinase gelatinase B. J Biol Chem. 275:10405–10412. 2000.
View Article : Google Scholar
|
|
38
|
Abusnina A, Keravis T, Yougbare I, Bronner
C and Lugnier C: Anti-proliferative effect of curcumin on melanoma
cells is mediated by PDE1A inhibition that regulates the epigenetic
integrator UHRF1. Mol Nutr Food Res. 55:1677–1689. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Premanand C, Rema M, Sameer MZ, Sujatha M
and Balasubramanyam M: Effect of curcumin on proliferation of human
retinal endothelial cells under in vitro conditions. Invest
Ophthalmol Vis Sci. 47:2179–2184. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Alex AF, Spitznas M, Tittel AP, Kurts C
and Eter N: Inhibitory effect of epigallocatechin gallate (EGCG),
resveratrol, and curcumin on proliferation of human retinal pigment
epithelial cells in vitro. Curr Eye Res. 35:1021–1033. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Pastor-Idoate S, Rodríguez-Hernandez I,
Rojas J, et al: The T309G MDM2 gene polymorphism is a novel risk
factor for proliferative vitreoretinopathy. PLoS One. 8:e822832013.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Jin GF, Hurst JS and Godley BF: Hydrogen
peroxide stimulates apoptosis in cultured human retinal pigment
epithelial cells. Curr Eye Res. 22:165–173. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Mahyar-Roemer M and Roemer K: p21
Waf1/Cip1 can protect human colon carcinoma cells against
p53-dependent and p53-independent apoptosis induced by natural
chemopreventive and therapeutic agents. Oncogene. 20:3387–3398.
2001. View Article : Google Scholar
|
|
44
|
Tian H, Wittmack EK and Jorgensen TJ:
p21WAF1/CIP1antisense therapy radiosensitizes human
colon cancer by converting growth arrest to apoptosis. Cancer Res.
60:679–684. 2000.
|
|
45
|
Xu GW, Nutt CL, Zlatescu MC, Keeney M,
Chin-Yee I and Cairncross JG: Inactivation of p53 sensitizes U87MG
glioma cells to 1,3-bis(2-chloroethyl)-1-nitrosourea. Cancer Res.
61:4155–4159. 2001.PubMed/NCBI
|
|
46
|
Han J, Yuan Z and Yan H: Inhibitory effect
of adenoviral vector-mediated delivery of p21WAF1/CIP1on
retinal vascular endothelial cell proliferation and tube formation
in cultured Rhesus monkey cells (RF/6A). Curr Eye Res. 38:670–673.
2013.PubMed/NCBI
|
|
47
|
Wei SC, Lin YS, Tsao PN, Wu-Tsai JJ, Wu CH
and Wong JM: Comparison of the anti-proliferation and
apoptosis-induction activities of sulindac, celecoxib, curcumin,
and nifedipine in mismatch repair-deficient cell lines. J Formos
Med Assoc. 103:599–606. 2004.PubMed/NCBI
|
|
48
|
Kirchmaier AL: Ub-family modifications at
the replication fork: Regulating PCNA-interacting components. FEBS
Lett. 585:2920–2928. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Strzalka W and Ziemienowicz A:
Proliferating cell nuclear antigen (PCNA): a key factor in DNA
replication and cell cycle regulation. Ann Bot. 107:1127–1140.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Cazzalini O, Perucca P, Riva F, et al:
p21CDKN1A does not interfere with loading of PCNA at DNA
replication sites, but inhibits subsequent binding of DNA
polymerase delta at the G1/S phase transition. Cell Cycle.
2:596–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Yang Y, Tarapore RS, Jarmel MH, Tetreault
MP and Katz JP: p53 mutation alters the effect of the esophageal
tumor suppressor KLF5 on keratinocyte proliferation. Cell Cycle.
11:4033–4039. 2012. View Article : Google Scholar : PubMed/NCBI
|
